Literature DB >> 15886490

Lipopolysaccharide-induced cytokine and chemokine expression in human carotid lesions.

Ken Jatta1, Dick Wågsäter, Lars Norgren, Björn Stenberg, Allan Sirsjö.   

Abstract

The release of cytokines and chemokines from activated immune-competent cells plays a crucial role in determining the pathology of the atherogenic progress. We investigated the effect of bacterial lipopolysaccharide (LPS) on cytokine/chemokine expression in carotid lesions and normal renal arteries. The lesions or renal arteries were incubated for 6 h at 37 degrees C in serum-free media treated with or without LPS. After LPS treatment, increased protein levels of IL-1beta, IL-6, IL-8, IL-10, TNF-alpha and MCP-1 were observed in the culture medium from the lesions measured with cytometric bead array. We were able to detect the induction of IL-1beta, IL-6, IL-8, IL-10, TNF-alpha and MCP-1 mRNA in the lesions after stimulation with LPS using real-time PCR. In renal arteries, LPS also induces mRNA expression of all chemokines and cytokines investigated with the exception of IL-6. However, LPS induces significantly higher levels of TNF-alpha, IL-1beta and IL-10 mRNA in lesions compared to renal arteries. The results suggest that infectious agents are capable of enhancing the production of cytokines/chemokines in an already ongoing inflammatory process such as in atherosclerosis, and that low levels of circulating LPS may affect the levels of pro-inflammatory cytokines much more in atherosclerotic vessels than in normal vessels and may contribute to the development of the atherosclerotic lesion. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886490     DOI: 10.1159/000085721

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  5 in total

1.  VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genes.

Authors:  Ruben Papoian; Andreas Scherer; Muriel Saulnier; Frank Staedtler; André Cordier; Francois Legay; Gerard Maurer; Joerg Staeheli; Jacky Vonderscher; Salah-Dine Chibout
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

2.  Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-κB pathway inhibition.

Authors:  Chien-Hung Lin; Chung-Ching Lin
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

3.  Positive affective style covaries with stimulated IL-6 and IL-10 production in a middle-aged community sample.

Authors:  Aric A Prather; Anna L Marsland; Matthew F Muldoon; Stephen B Manuck
Journal:  Brain Behav Immun       Date:  2007-06-04       Impact factor: 7.217

4.  Peripheral Blood Lymphocyte Subsets (CD4+, CD8+ T Cells, NK Cells) in Patients with Cardiovascular and Neurological Complications after Carotid Endarterectomy.

Authors:  Katarzyna Kotfis; Jowita Biernawska; Małgorzata Zegan-Barańska; Maciej Żukowski
Journal:  Int J Mol Sci       Date:  2015-05-04       Impact factor: 5.923

5.  JNK1 Mediates Lipopolysaccharide-Induced CD14 and SR-AI Expression and Macrophage Foam Cell Formation.

Authors:  Dong An; Feng Hao; Chen Hu; Wei Kong; Xuemin Xu; Mei-Zhen Cui
Journal:  Front Physiol       Date:  2018-01-05       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.